Showcases Stock ranks Forex

Bausch Health Companies Inc. (BHC)
17.19  -0.19 (-1.09%) 09-18 16:00
Open: 17.44 Pre. Close: 17.38
High: 17.57 Low: 16.88
Volume: 4,021,568 Market Cap: 6,086M
Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 21,100 full-time employees. The company primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. The company also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 17.574 - 17.663 17.663 - 17.72
Low: 16.671 - 16.787 16.787 - 16.861
Close: 17.022 - 17.199 17.199 - 17.312
Stock Technical Analysis
Target: Six months: 20.97
One year: 24.49
Support: Support1: 16.24
Support2: 15.18
Resistance: Resistance1: 17.95
Resistance2: 20.97
Pivot: 16.36
Moving Averages: MA(5): 16.72
MA(20): 16.49
MA(100): 17.77
MA(250): 21.42
MACD: MACD(12,26): -0.21
Signal(12,26,9): -0.39
%K %D: %K(14,3): 82.25
%D(3): 69.40
RSI: RSI(14): 54.12
52-Week: High: 31.97
Low: 11.15
Change(%): -23.8
Average Vol(K): 3-Month: 428804
10-Days: 477695
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

BHC has closed below upper band by 11.0%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 18 Sep 2020
Renewed Optimism is Surrounding Bausch Health Companies Inc. (NYSE:BHC) - The Oracle Dispatch

Thu, 17 Sep 2020
Bausch Health Companies Inc. (BHC) Management Presents at Morgan Stanley Global Healthcare Conference Call Transcript - Seeking Alpha

Thu, 17 Sep 2020
Where Does Bausch Health Companies Inc (BHC) Stock Fall in the Drug Manufacturers - Specialty & Generic Field? - InvestorsObserver

Wed, 16 Sep 2020
Bausch Health Companies Inc (BHC) Stock: What Does the Chart Say? - InvestorsObserver

Wed, 16 Sep 2020
Why Buy stock in Bausch Health Companies Inc. (BHC)? - Marketing Sentinel

Wed, 16 Sep 2020
Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference - Yahoo Finance

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 354.99
Shares Float (M) 309.30
% Held by Insiders 0.55
% Held by Institutions 66.95
Shares Short (K) 17850
Shares Short Prior Month (K) 17230
Stock Financials
EPS -5.780
Book Value (p.s.) 1.340
Profit Margin -25.19
Operating Margin 14.08
Return on Assets (ttm) 2.2
Return on Equity (ttm) -126.3
Qtrly Rev. Growth -22.7
Gross Profit (p.s.) 17.606
Sales Per Share 22.846
EBITDA (p.s.) 8.789
Qtrly Earnings Growth
Operating Cash Flow (M) 1210.00
Levered Free Cash Flow (M) 1880.00
Stock Valuation
PE Ratio -2.97
PEG Ratio
Price to Book value 12.83
Price to Sales 0.75
Price to Cash Flow 5.04
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator